Edwards Lifesciences Corporation (1EW)
Market Closed
17 Jul, 15:30
€
75. 52
-5.26
-6.5115%
€
43.33B Market Cap
32.12 P/E Ratio
- Div Yield
1 Volume
2.51 Eps
€ 80.78
Previous Close Want to track 1EW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Edwards Lifesciences Corporation (1EW) Statistics
Valuation metrics
Market Cap 43.33B
Enterprise value 31.6B
Trailing P/E (ttm) 44.46
Forward P/E -
PEG ratio -0.59
Price/Sales (ttm) 6.94
Price/Book (mrq) 4.52
Enterprise Value/Revenue 5.97
Enterprise Value/EBITDA 20.2
Overview
Shares outstanding 580.7M
Float 579.02M
Shares short -
% Held by insiders 0%
% Held by institutions 0.92%
Average volume (10 days) 2
Average volume (90 days) 5
Price summary
52-Week low 63.84
52-Week high 82.24
Beta 0.93
50-Day moving average 70.23
200-Day moving average 69.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 1 Jun 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.18%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.1%
Income Statement
Revenue (ttm) 5.29B
Revenue per share (ttm) 10.38
Quarterly revenue growth (yoy) 0.13%
Gross profit (ttm) 4.13B
EBITDA 1.96B
Net income to common (ttm) 924.25M
Diluted EPS (ttm) 1.58
Quarterly earnings growth (yoy) -0.76%
Balance Sheet
Total cash (mrq) 3.68B
Total cash per share (mrq) 7.28
Total debt (mrq) 615M
Total Debt/Equity (mrq) 6.82
Current ratio (mrq) 3.72%
Book value per share (mrq) 15.54
Cash Flow
Cash flow statement 1.39B
Levered free cash flow (LFCF) 1.02B
